Overview

The Feasibility of Florbetapir Quantitation in Europe

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
0
Participant gender:
All
Summary
This study will evaluate whether the addition of quantitation as an adjunct to visual interpretations significantly improves the accuracy of Amyvid scan interpretation.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Avid Radiopharmaceuticals
Criteria
Inclusion Criteria:

- Readers have undergone Amyvid reader training

- Readers have not more than minimal experience with quantitation of amyloid PET scans

Exclusion Criteria:

- Readers have previously been trained to quantitate amyloid PET scans